| pubmed-article:21302449 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C0178587 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C0442726 | lld:lifeskim |
| pubmed-article:21302449 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
| pubmed-article:21302449 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21302449 | pubmed:dateCreated | 2011-2-8 | lld:pubmed |
| pubmed-article:21302449 | pubmed:abstractText | To investigate the clinical significance of tumor microvascular density (MVD) detected by anti-CD105 and anti-CD34 as a predictor of recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT). | lld:pubmed |
| pubmed-article:21302449 | pubmed:language | chi | lld:pubmed |
| pubmed-article:21302449 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21302449 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21302449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21302449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21302449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21302449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21302449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21302449 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21302449 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:21302449 | pubmed:issn | 1672-173X | lld:pubmed |
| pubmed-article:21302449 | pubmed:author | pubmed-author:PageN RNR | lld:pubmed |
| pubmed-article:21302449 | pubmed:author | pubmed-author:WangYuY | lld:pubmed |
| pubmed-article:21302449 | pubmed:author | pubmed-author:YanLü-nanLN | lld:pubmed |
| pubmed-article:21302449 | pubmed:author | pubmed-author:ZhangXiu-huiX... | lld:pubmed |
| pubmed-article:21302449 | pubmed:author | pubmed-author:DuHeH | lld:pubmed |
| pubmed-article:21302449 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21302449 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:21302449 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21302449 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21302449 | pubmed:pagination | 818-21 | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:meshHeading | pubmed-meshheading:21302449... | lld:pubmed |
| pubmed-article:21302449 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21302449 | pubmed:articleTitle | [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation]. | lld:pubmed |
| pubmed-article:21302449 | pubmed:affiliation | Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China. | lld:pubmed |
| pubmed-article:21302449 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21302449 | pubmed:publicationType | English Abstract | lld:pubmed |
